Lab (LH) 4: ANDERSON KERRII B bought 897 shares of Common Stock at $N/A… (Feb 13, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: LABCORP HOLDINGS INC. (LH) CIK: 0000920148 --- Reporting Owner --- Name: ANDERSON KERRII B CIK: 0001227159 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-02-11 | Code: M (Exercise of derivative) Shares: +897 Shares Owned After: 9,563 | Ownership: D (Direct) Footnotes: [F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-02-11 | Code: M (Exercise of derivative) Shares: -897 | Price: $0.00 Shares Owned After: 773 | Ownership: D (Direct) Footnotes: [F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. [F2] The Restricted Stock Units vested fully on February 11, 2026. [F2] The Restricted Stock Units vested fully on February 11, 2026. [F3] This number reflects the aggregate number of Restricted Stock Units held by the reporting person. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) [Holding #2] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2: The Restricted Stock Units vested fully on February 11, 2026. F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. --- Signature --- /s/ /s/ Kathryn W. Kyle Attorney-in-Fact for Kerrii B. Anderson (2026-02-13)